Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03354130
Other study ID # PP201711-15
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 21, 2017
Est. completion date August 30, 2018

Study information

Verified date November 2018
Source International Agency for Research on Cancer
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The intake of processed meat products has been linked to several adverse health outcomes. However, estimation of their intake proves difficult. This study aims at identifying biomarkers of intake for processed meat products in blood and urine. For this, participants of a randomized cross-over dietary intervention will consume highly controlled diets containing non-processed pork, different processed meat products or no meat. Urine and plasma will be collected and analysed to identify sets of metabolites that are specific for the intake of the processed meat products.


Description:

The intake of processed meat has been linked to several adverse health outcomes such as cancer. However, little is known about the respective effects of the single products in this diverse group.

Most epidemiological studies rely on self-reported questionnaires to assess the intake of different foods. Even though this method is relatively easy to perform, it is prone to errors such as memory biases of subjects or difficulties in estimating portion size. The use of food specific biomarkers may overcome this limitation by offering an objective quantification of dietary exposure. No biomarkers for the consumption of processed meat products have been established yet.

Twelve human healthy adults will participate in a randomized cross-over dietary intervention study and will consume three different processed meat products, fresh meat or no meat, each during 3 successive days followed by a 10-day washout period. The metabolite profile in urine and plasma samples will be analysed to find metabolites that are specific for the intake of the processed meat products.

The identification of these biomarkers in blood and urine will allow a more precise estimation of intake of different processed meat products. This will enable a more robust estimation of the risk linked to the intake of processed meat products.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date August 30, 2018
Est. primary completion date March 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- BMI 18-30

- Healthy

Exclusion Criteria:

- Vegetarians

- Smokers

Study Design


Related Conditions & MeSH terms

  • Biomarkers of Processed Meat Intake in Healthy Subjects

Intervention

Other:
Processed meat dietary intervention
Randomized cross-over dietary intervention with 5 different diets

Locations

Country Name City State
France International Agency for Research on Cancer Lyon

Sponsors (1)

Lead Sponsor Collaborator
International Agency for Research on Cancer

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Plasma biomarkers of meat intake Plasma samples will be analysed by UPLC-MS to identify metabolites specific for processed meat intake After approx. 60 h of dietary intervention
Primary Urinary biomarkers of meat intake Urine samples will be analysed by UPLC-MS to identify metabolites specific for processed meat intake After approx. 48 h of dietary intervention
Secondary Biomarkers of meat intake in spot urine Spot urine samples will be analysed by UPLC-MS to identify metabolites specific for processed meat intake 2 hours after the first dinner of each intervention period
Secondary Biomarkers of meat intake in spot urine Spot urine samples will be analysed by UPLC-MS to identify metabolites specific for processed meat intake Approx. 12 h after the first dinner of each intervention period